Bayer health consumer products China R&D center is officially opened in Qidong, Jiangsu province. The newly completed R&D center in China is one of the four R&D centers of bayer health consumer products in the world and the only R&D center located in the Asia-pacific region. It will support all product categories of bayer health consumer products in China and provide better self-care solutions for Chinese consumers.
The new R&D center has a number of functional laboratories, including solid preparations, semi-solid preparations, liquid preparations and other development platforms, and the R&D team will apply a variety of innovation models to promote growth centered innovation, including category innovation, product line expansion, technical support and protection of existing listed products.
Song yuqun, head of product supply in China for bayer health consumer products, said: "the establishment of the R&D center also enables our production team to get involved in the early development of new products and shorten the launch cycle of new products with the company's cutting-edge innovation. We are also able to feed back the production information to the R&D team as soon as possible. The two sides work closely together to continuously provide high-quality products for Chinese consumers in the spirit of craftsman and fulfill bayer health consumer products' mission of enabling health every day.
Source: Bayer (China)
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year